Elekta AB (publ) (EKTA-B.ST)
SEK 61.7
(2.32%)
SEK 61.7
(2.32%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 4.46 Billion SEK | 31.52% |
| 2022 | 3.39 Billion SEK | 29.4% |
| 2021 | 2.62 Billion SEK | 43.03% |
| 2020 | 1.83 Billion SEK | -37.95% |
| 2019 | 2.95 Billion SEK | 500.2% |
| 2018 | 493 Million SEK | -44.36% |
| 2017 | 886 Million SEK | -53.1% |
| 2016 | 1.88 Billion SEK | -29.44% |
| 2015 | 2.67 Billion SEK | -3.29% |
| 2014 | 2.76 Billion SEK | 23.63% |
| 2013 | 2.23 Billion SEK | 12.8% |
| 2012 | 1.98 Billion SEK | -24.67% |
| 2011 | 2.63 Billion SEK | 646.68% |
| 2010 | -482 Million SEK | -147.35% |
| 2009 | 1.01 Billion SEK | 27.41% |
| 2008 | 799 Million SEK | -23.69% |
| 2007 | 1.04 Billion SEK | 108.15% |
| 2006 | 503 Million SEK | 357.27% |
| 2005 | 110 Million SEK | 23.6% |
| 2004 | 89 Million SEK | 111.63% |
| 2003 | -765 Million SEK | -25.2% |
| 2002 | -611 Million SEK | -21.96% |
| 2001 | -501 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 5.37 Billion SEK | 20.34% |
| 2023 FY | 4.46 Billion SEK | 31.52% |
| 2023 Q3 | 4.79 Billion SEK | -3.78% |
| 2023 Q4 | 4.46 Billion SEK | -6.7% |
| 2023 Q1 | 4.37 Billion SEK | 28.87% |
| 2023 Q2 | 4.97 Billion SEK | 13.68% |
| 2022 Q2 | 4.17 Billion SEK | 27.41% |
| 2022 Q3 | 4.42 Billion SEK | 5.92% |
| 2022 FY | 3.39 Billion SEK | 29.4% |
| 2022 Q1 | 3.27 Billion SEK | 24.75% |
| 2022 Q4 | 3.39 Billion SEK | -23.14% |
| 2021 Q3 | 2.81 Billion SEK | -0.81% |
| 2021 Q4 | 2.62 Billion SEK | -6.78% |
| 2021 FY | 2.62 Billion SEK | 43.03% |
| 2021 Q2 | 2.84 Billion SEK | 28.27% |
| 2021 Q1 | 2.21 Billion SEK | 20.59% |
| 2020 Q4 | 1.83 Billion SEK | -15.7% |
| 2020 Q2 | 3.05 Billion SEK | -1.29% |
| 2020 FY | 1.83 Billion SEK | -37.95% |
| 2020 Q1 | 3.09 Billion SEK | 4.6% |
| 2020 Q3 | 2.17 Billion SEK | -28.71% |
| 2019 Q1 | 2.47 Billion SEK | 402.64% |
| 2019 FY | 2.95 Billion SEK | 500.2% |
| 2019 Q2 | 2.81 Billion SEK | 13.4% |
| 2019 Q3 | 3.44 Billion SEK | 22.74% |
| 2019 Q4 | 2.95 Billion SEK | -14.21% |
| 2018 Q4 | 493 Million SEK | -68.5% |
| 2018 FY | 493 Million SEK | -44.36% |
| 2018 Q3 | 1.56 Billion SEK | 17.14% |
| 2018 Q2 | 1.33 Billion SEK | -3.95% |
| 2018 Q1 | 1.39 Billion SEK | 57.0% |
| 2017 Q1 | 1.91 Billion SEK | 1.27% |
| 2017 Q4 | 886 Million SEK | -42.47% |
| 2017 FY | 886 Million SEK | -53.1% |
| 2017 Q3 | 1.54 Billion SEK | -23.95% |
| 2017 Q2 | 2.02 Billion SEK | 5.85% |
| 2016 Q4 | 1.88 Billion SEK | -33.63% |
| 2016 Q2 | 3.05 Billion SEK | 0.89% |
| 2016 Q3 | 2.84 Billion SEK | -6.96% |
| 2016 FY | 1.88 Billion SEK | -29.44% |
| 2016 Q1 | 3.03 Billion SEK | 13.26% |
| 2015 Q1 | 3.4 Billion SEK | 22.94% |
| 2015 Q3 | 3.36 Billion SEK | -2.63% |
| 2015 FY | 2.67 Billion SEK | -3.29% |
| 2015 Q2 | 3.45 Billion SEK | 1.53% |
| 2015 Q4 | 2.67 Billion SEK | -20.42% |
| 2014 Q1 | 3 Billion SEK | 34.21% |
| 2014 Q4 | 2.76 Billion SEK | -31.23% |
| 2014 Q3 | 4.02 Billion SEK | 8.11% |
| 2014 FY | 2.76 Billion SEK | 23.63% |
| 2014 Q2 | 3.72 Billion SEK | 23.89% |
| 2013 Q1 | 2.63 Billion SEK | 32.64% |
| 2013 Q3 | 3.3 Billion SEK | 1.66% |
| 2013 Q2 | 3.24 Billion SEK | 23.28% |
| 2013 Q4 | 2.23 Billion SEK | -32.15% |
| 2013 FY | 2.23 Billion SEK | 12.8% |
| 2012 FY | 1.98 Billion SEK | -24.67% |
| 2012 Q4 | 1.98 Billion SEK | -29.66% |
| 2012 Q3 | 2.82 Billion SEK | -2.56% |
| 2012 Q2 | 2.89 Billion SEK | -30.63% |
| 2012 Q1 | 4.17 Billion SEK | 58.44% |
| 2011 Q1 | -600 Million SEK | -24.48% |
| 2011 Q4 | 2.63 Billion SEK | -8.38% |
| 2011 Q3 | 2.87 Billion SEK | -3.1% |
| 2011 FY | 2.63 Billion SEK | 646.68% |
| 2011 Q2 | 2.96 Billion SEK | 594.67% |
| 2010 Q1 | 173 Million SEK | -83.01% |
| 2010 FY | -482 Million SEK | -147.35% |
| 2010 Q3 | -109 Million SEK | -107.81% |
| 2010 Q4 | -482 Million SEK | -342.2% |
| 2010 Q2 | 1.39 Billion SEK | 706.36% |
| 2009 Q4 | 1.01 Billion SEK | 0.0% |
| 2009 FY | 1.01 Billion SEK | 27.41% |
| 2008 FY | 799 Million SEK | -23.69% |
| 2007 FY | 1.04 Billion SEK | 108.15% |
| 2006 FY | 503 Million SEK | 357.27% |
| 2005 FY | 110 Million SEK | 23.6% |
| 2004 FY | 89 Million SEK | 111.63% |
| 2003 FY | -765 Million SEK | -25.2% |
| 2002 FY | -611 Million SEK | -21.96% |
| 2001 FY | -501 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AddLife AB (publ) | 5.01 Billion SEK | 10.923% |
| Biotage AB (publ) | -444 Million SEK | 1106.532% |
| Bonesupport Holding AB (publ) | -149.86 Million SEK | 3081.977% |
| Doxa AB (publ) | -102.2 Million SEK | 4472.798% |
| iZafe Group AB (publ) | -2.65 Million SEK | 168170.703% |
| Ortivus AB (publ) | 4.19 Million SEK | -106507.824% |
| Ortivus AB (publ) | 4.19 Million SEK | -106507.824% |
| Q-linea AB (publ) | -61.33 Million SEK | 7386.809% |
| S2Medical AB (publ) | -1.51 Million SEK | 294689.157% |
| Synsam AB (publ) | 2.67 Billion SEK | -67.19% |